ArticleAnti-cancer agents in medicinal chemistry2025

Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent Transcription.

Sara Sigler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.